Showing 12 of 12 results
- CRISPR disruption screen of WTC11Homo sapiens WTC11 genetically modified using CRISPR, transduction treated with 240 ng/mL tioguanine for 7 daysLab: Yin Shen, UCSFProject: ENCODETreatment: tioguanine (CHEBI:9555) for 7 days
- CRISPR disruption screen of WTC11Homo sapiens WTC11 genetically modified using CRISPR, transduction treated with 80 ng/mL tioguanine for 7 daysLab: Yin Shen, UCSFProject: ENCODETreatment: tioguanine (CHEBI:9555) for 7 days
- CRISPR interference screen of WTC11Homo sapiens WTC11 genetically modified using CRISPR, transduction treated with 80 ng/mL tioguanine for 7 daysLab: Yin Shen, UCSFProject: ENCODETreatment: tioguanine (CHEBI:9555) for 7 days
- Control CRISPR screen of WTC11Homo sapiens WTC11 genetically modified using CRISPR, transductionLab: Yin Shen, UCSFProject: ENCODE
- Control CRISPR screen of WTC11Homo sapiens WTC11 genetically modified using CRISPR, transductionLab: Yin Shen, UCSFProject: ENCODE
- pooled clone sequencing of DNA cloning sampleLab: Yin Shen, UCSFProject: ENCODE
- pooled clone sequencing of DNA cloning sampleLab: Bing Ren, UCSDProject: ENCODE
- pooled clone sequencing of DNA cloning sampleLab: Tim Reddy, DukeProject: GGR
- STARR-seq of SH-SY5YHomo sapiens SH-SY5Y genetically modified using transient transfectionLab: Kevin White, UChicagoProject: ENCODE
- pooled clone sequencing of DNA cloning sampleLab: Kevin White, UChicagoProject: ENCODE
- pooled clone sequencing of DNA cloning sampleLab: Kevin White, UChicagoProject: ENCODE
- pooled clone sequencing of DNA cloning sampleLab: Kevin White, UChicagoProject: ENCODE